Press release submitted on behalf of DEMGY.
Class 7 cleanroom will be fully operational before MD&M Midwest.
DEMGY Chicago is expanding its medical manufacturing capabilities with an ISO Class 7 cleanroom that will be fully operational before the start of MD&M Midwest, which runs October 28–29, 2026, in Minneapolis. DEMGY Chicago continues to improve their existing vision inspection capabilities to strengthen quality control, including checks for distortion in molded components.
With an ISO 13485-certified facility already offering injection molding in ISO Class 8 cleanrooms, along with mold design and manufacturing, CNC machining, and assembly, DEMGY Chicago’s new Class 7 cleanroom will expand their controlled-environment production capabilities for medical device manufacturers.
Vision inspection capabilities check molded components for distortion, helping evaluate whether a part maintains the shape required for its application. The focused inspection supports the company’s work with complex medical components, where part geometry can affect fit and function and conformance to specified tolerances is critical.
An established endoscopy handle program illustrates DEMGY’s approach to high-volume medical production. Automation removes the single-use device components from the press, performs 100% dimensional and visual inspection, and packs the parts without direct human contact. DEMGY reports a 20% reduction in cycle time for the program and no customer claims in more than five years.
About DEMGY Chicago
Based in Elk Grove Village, Illinois, DEMGY Chicago designs and manufactures thermoplastic components and assemblies for medical, aerospace, and industrial applications. Part of the DEMGY Group, the facility combines tooling building capability, injection molding, machining, assembly, and inspection. Learn more at demgy.com.
About DEMGY Group:
DEMGY Group is an international technology company specializing in weight reduction through its high-performance plastic and composite solutions that are lighter than metal.
In 2004, Pierre-Jean Leduc, who had managed and developed Dedienne since 1991, took over the company (founded in 1947) as Chairman & CEO in an MBO, to create DEMGY Group. Since then, DEMGY has experienced continuous growth based on innovation, internationalization and technological advancement through organic and external growth.
Following its latest acquisition in the USA in March 2025, the group became the world leader in plastic and composite components for aircraft cabins, a Tier 1 supplier to Airbus, Boeing and the largest aerospace equipment manufacturers.
With facilities in France (4 sites, including headquarters in Normandy), Germany (two sites), Romania (two sites) and the United States (two sites), the Group also has three R&D centers and sales offices in England and Israel.
In 2025, DEMGY achieved revenues of $150 million, 7% of which was reinvested in R&D and industrial equipment, and employed 900 people. DEMGY is forecasting revenues of $230 million and a headcount of 1,400 by 2030.